60.9 F
San Diego
Monday, May 29, 2023
-Advertisement-

SD500 2022: James Mackay

PRESIDENT & CEO, ARISTEA THERAPEUTICS

Dr. James Mackay has over 25 years of development and commercialization expertise in the pharmaceutical industry, including six drug product approvals across multiple therapeutic areas. Prior to founding Aristea, he was president and CEO of Ardea Biosciences, following the company’s acquisition by AstraZeneca in 2012. Mackay is board chair at CONNECT, sits on BIOCOM’s board and is a past board member at the San Diego Regional EDC 

-Advertisement-

Featured Articles

-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-
-Advertisement-